These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 25468095)
1. Type A aortic dissection in a patient on dabigatran: hemostasis post circulatory arrest. Ashikhmina E; Tomasello N; Connors JM; Jahanyar J; Davidson M; Mizuguchi KA Ann Thorac Surg; 2014 Dec; 98(6):2215-6. PubMed ID: 25468095 [TBL] [Abstract][Full Text] [Related]
2. Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation. Lillo-Le Louët A; Wolf M; Soufir L; Galbois A; Dumenil AS; Offenstadt G; Samama MM Thromb Haemost; 2012 Sep; 108(3):583-5. PubMed ID: 22782645 [No Abstract] [Full Text] [Related]
5. [Dabigatran in prevention of stroke in atrial fibrillation: three years of clinical application]. Zotova IV; Zateĭshchikov DA Kardiologiia; 2014; 54(2):79-85. PubMed ID: 24888206 [No Abstract] [Full Text] [Related]
6. Gastrointestinal bleeding associated with dabigatran in a patient with panhypopituitarism. Gunes F; Asik M; Temiz A; Binnetoglu E; Sen H; Bilen Oİ; Akbal E; Adam G; Ukinc K Wien Klin Wochenschr; 2014 Jan; 126(1-2):62-3. PubMed ID: 24240609 [No Abstract] [Full Text] [Related]
7. Thrombolysis in ischemic stroke patients on treatment with Dabigatran. Re G; Toni D Intern Emerg Med; 2013 Aug; 8(5):451-2. PubMed ID: 23389386 [No Abstract] [Full Text] [Related]
8. Thromboprophylaxis with dabigatran leads to an increased incidence of wound leakage and an increased length of stay after total joint replacement. Bloch BV; Patel V; Best AJ Bone Joint J; 2014 Jan; 96-B(1):122-6. PubMed ID: 24395322 [TBL] [Abstract][Full Text] [Related]
9. Coronary embolization following electrical cardioversion in a patient treated with dabigatran. Gagliardi L; Guerbaai RA; Marlière S; Bouvaist H; Ennezat PV Int J Cardiol; 2014 Aug; 175(3):571-2. PubMed ID: 24861253 [No Abstract] [Full Text] [Related]
10. [Aneurysm of abdominal aorta rupture in a patient on dabigatran treatment]. Aubert J; Delalande JP; Skowronski P Ann Fr Anesth Reanim; 2013 Apr; 32(4):271-2. PubMed ID: 23490462 [No Abstract] [Full Text] [Related]
11. Effects of thromboembolism prophylaxis with dabigatran on perioperative blood loss and wound secretion in primary hip arthroplasty. Mommsen P; Doering M; R O Hrs E; Egidy C; Gehrke T; Krettek C; Kendoff D Technol Health Care; 2014; 22(6):901-8. PubMed ID: 25318954 [TBL] [Abstract][Full Text] [Related]
12. Reversible Cognitive Impairment Associated with the Use of Dabigatran. La Brooy B; Ho P; Lim K J Am Geriatr Soc; 2015 Aug; 63(8):1717-9. PubMed ID: 26289705 [No Abstract] [Full Text] [Related]
13. What is the role of renal replacement therapy in the setting of dabigatran toxicity? Ghannoum M; Nolin TD Semin Dial; 2014; 27(3):223-6. PubMed ID: 24620942 [No Abstract] [Full Text] [Related]
14. [Extensive thromboembolism after cardioversion in a patient treated with dabigatran]. Buch TN; Holm J; Munck LK Ugeskr Laeger; 2013 Feb; 175(6):333-4. PubMed ID: 23402235 [TBL] [Abstract][Full Text] [Related]
15. Management of dabigatran-induced bleeding: expert statement. Fries D; Giurea A; Gütl M; Halbmayer WM; Kozek-Langenecker S; Pachucki A; Roithinger F; Steinlechner B; Thaler H; Weltermann A Wien Klin Wochenschr; 2013 Nov; 125(21-22):721-9. PubMed ID: 24217941 [TBL] [Abstract][Full Text] [Related]
16. [Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery]. Bachellerie B; Ruiz S; Conil JM; Crognier L; Seguin T; Georges B; Fourcade O Ann Fr Anesth Reanim; 2014 Jan; 33(1):44-6. PubMed ID: 24378048 [TBL] [Abstract][Full Text] [Related]
18. Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. Warkentin TE; Margetts P; Connolly SJ; Lamy A; Ricci C; Eikelboom JW Blood; 2012 Mar; 119(9):2172-4. PubMed ID: 22383791 [No Abstract] [Full Text] [Related]
19. [Dabigatran as cause of severe gastrointestinal bleeding in a Jehovah's Witness patient]. Holm J; Taskiran M Ugeskr Laeger; 2013 Feb; 175(6):334-6. PubMed ID: 23402236 [TBL] [Abstract][Full Text] [Related]
20. [Extrapolation of physiopathological data to clinical practice: Example of dabigatran in off-label use]. Molinier A; Acket B; Bourrel R; Lavezzi O; Montastruc JL; Bagheri H Presse Med; 2014 Apr; 43(4 Pt 1):468-9. PubMed ID: 24534477 [No Abstract] [Full Text] [Related] [Next] [New Search]